I have been working with the Barnes group alongside my clinical training for several years. Much of my work has been focused on translational cellular immunology in immune mediated hepatobiliary disease. Recently I have been awarded a Welcome Trust Clinical Fellowship to undertake a PhD on HBV immunotherapy within the vaccine group.
I am interested in harnessing cellular immunology to understand disease pathogenesis and develop novel treatment strategies for hepatobiliary conditions.
IgG4-Related Disease Study: Natural history and pathogenesis
Immunotherapy for chronic Hepatitis B infection
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry.
Moon AM. et al, (2020), J Hepatol, 73, 705 - 708
Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease.
Goodchild G. et al, (2020), Clin Med (Lond), 20, e32 - e39
Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis.
Culver EL. et al, (2019), J Gastroenterol Hepatol, 34, 1878 - 1886
A systematic review of comorbidities and outcomes of adult patients with pleural infection.
Cargill TN. et al, (2019), Eur Respir J, 54
Correction: Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis.
Cargill T. et al, (2019), Clin Transl Gastroenterol, 10